SUBJECT-0162.dossier · company · status: active
BN
subject of file

Blackrock Neurotech

Brain-computer interface company backed by Peter Thiel (no connection to BlackRock Inc.)
Tracked because Brain-computer interface company backed by Peter Thiel (no connection to BlackRock Inc.) · 7 documented connections
Facts on record13
Connections mapped7
Sources cited16
Evidence: 8P 2S 3I
Network web → Timeline → Compare with… → Position Drift → Coverage tone → View on Graph → View Card → Export CSV JSON Dossier ← Entity Directory
🧠 Cognitive harm via shared boards / co-investments
Inferential confidence
Tracked platforms owned by entities this person sits on a board with, founded with, or co-invested in.
1 documented harm · Documented
via Peter Thiel (investor)
Rumble
40
1 documented harm · Moderate
via Peter Thiel (investor)
Inferred path: each card shows the connecting entity. See full methodology →
Stated vs Revealed
No documented contradictions on file.
PATTERN elected official → [donor] → person → [investor] → company 2167× PATTERN organization → [donor] → person → [investor] → company 235× PATTERN company → [founder] → person → [investor] → company 233× PATTERN company → [investor] → person → [investor] → company 191× PATTERN person → [investor] → person → [investor] → company 152×
Connection Map
Key Connections
→ US Food and Drug Administration (FDA) institution
regulator
The FDA granted Breakthrough Device Designation to Blackrock Neurotech's MoveAgain system in 2021. The FDA also cleared the Utah Array in 2004 for temporary (≤30 days) monitoring.
→ BlackRock company
name confusion entity
In June 2025, Tether CEO Paolo Ardoino stated the company needed a name change to avoid confusion with BlackRock Inc.
← Peter Thiel person
investor
Participated as a key investor in the $10 million May 2021 financing round.
Facts (13)
Data Freshness
Ageing Last update: 159d ago · Avg age: 513d
Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing
✓ Verified Findings (10)
Independently re-checked: a second model read the source artifact and confirmed it supports the extracted claim.
✓ verified Pending Review Blackrock Neurotech was founded in Salt Lake City in 2008 by Marcus Gerhardt (CEO) and Florian Solzbacher (Chairman), a professor at the University of Utah.
Date: 2008-06-15 Added: 08 May 2026
✓ verified Pending Review The MoveAgain system, designed for home use, remains in the FDA pre-market approval (PMA) pathway as of May 2026; despite earlier company projections for commercial availability in 2023, no public announcement of full marketing authorization has been made.
Date: 2026-05-08 Added: 08 May 2026
✓ verified Primary Source Tether (via Tether Evo) acquired a majority stake in April 2024 for $200 million. In June 2025, Tether CEO Paolo Ardoino stated the company needed a name change to avoid confusion with BlackRock Inc. and expressed ambitions to build an 'open-source brain operating system.'
✓ verified Pending Review In August 2024, Blackrock Neurotech announced it had successfully restored the voice of an ALS patient using its BCI-to-text-to-speech interface, a project supported by the 2024 Tether capital infusion.
Date: 2024-08-16 Added: 08 May 2026
✓ verified Primary Source CFO Nathan Smith departed Blackrock Neurotech in August 2025 to join CareDx as CFO; he subsequently resigned from CareDx for personal reasons effective February 25, 2026.
Date: 2026-02-25 Added: 08 May 2026 ↗ SOURCE: CareDx 8-K: Resignation of CFO Nathan Smith
✓ verified Pending Review The company's core technology, the Utah Array, was cleared by the FDA in 2004 for temporary (≤30 days) monitoring; it is the most implanted invasive BCI platform, with over 30,000 cumulative days of human implant data recorded by 2024.
Date: 2004-06-15 Added: 08 May 2026
✓ verified Pending Review In April 2024, the stablecoin issuer Tether invested $200 million via its Tether Evo venture arm to acquire a majority stake in Blackrock Neurotech.
Date: 2024-04-29 Added: 02 May 2026 UNVERIFIED Stablecoin Giant Tether Invests $200M In Brain-Computer Interface Startup Blackr…
✓ verified Pending Review The company's core technology, the Utah Array (also known as the NeuroPort Electrode), received Breakthrough Device Designation from the FDA in 2021 for its MoveAgain system.
Date: 2021-06-15 Added: 02 May 2026 UNVERIFIED Our Tech | Blackrock Neurotech
✓ verified Pending Review In May 2021, Blackrock Neurotech closed a $10 million financing round led by Christian Angermayer's re.Mind Capital, with participation from Peter Thiel and the University Venture Fund II.
Date: 2021-05-19 Added: 02 May 2026 UNVERIFIED Blackrock Neurotech Closes $10M Financing Round
✓ verified Partially Corroborated Blackrock Neurotech filed filing with the SEC on 2023-02-23. Accession number: N/A.
All Connections (7)
→ Tether company
owner secondary
Tether acquired a majority stake in the company in April 2024 through a $200 million investment.
regulator primary since 2004
The FDA granted Breakthrough Device Designation to Blackrock Neurotech's MoveAgain system in 2021. The FDA also cleared the Utah Array in 2004 for temporary (≤30 days) monitoring.
→ BlackRock company
name confusion entity primary since 2025
In June 2025, Tether CEO Paolo Ardoino stated the company needed a name change to avoid confusion with BlackRock Inc.
← Peter Thiel person
investor primary
Participated as a key investor in the $10 million May 2021 financing round.
← Bear Stearns company
unconfirmed connection inferential since 2008
BlackRock Financial Management (same brand family) managed Bear Stearns' toxic assets. Blackrock Neurotech is a separate entity; connection unconfirmed.
← Circuit Therapeutics company
Industry Sector inferential since 2026
Both Circuit Therapeutics and Blackrock Neurotech appear in the database as entities in the neurotechnology/neural interface space, suggesting they may be competitors, collaborators, or part of the same research/investment ecosystem.
← Howard Lutnick person
indirect business inferential since 2025
Tether's investment arm Tether Evo holds a majority stake in Blackrock Neurotech, which is connected to Lutnick's family through Dynasty Trust A's Tether loan relationship.
Sources (16)
2023-03-01 ↗ SEC EDGAR: filing — Blackrock Neurotech (2023-03-01) sec_filing Processed 📜 Receipt
2022-03-09 ↗ SEC EDGAR: filing — Blackrock Neurotech (2022-03-09) sec_filing Processed 📜 Receipt
2026 UNVERIFIED Research: Blackrock Neurotech — Parliamentary records (no results) parliamentary_record Processed 📜 Receipt
2023-02-23 ↗ SEC EDGAR: filing — Blackrock Neurotech (2023-02-23) sec_filing Processed 📜 Receipt
2023-02-23 ↗ SEC EDGAR: D — Blackrock Neurotech SPV - Allocations Funds LLC (2023-02-23) sec_filing Processed 📜 Receipt
2026-05-10 UNVERIFIED SEARCH_ERROR: Blackrock Neurotech not found in opencorporates claim_flag Processed 📜 Receipt
2026 UNVERIFIED Research: Blackrock Neurotech — Court records (no results) court_document Processed 📜 Receipt
2026-02-24 ↗ CareDx 8-K: Resignation of CFO Nathan Smith external_handoff Processed 📜 Receipt
2025-06-25 ↗ Paolo Ardoino says Tether-backed BCI 'much more advanced' than Neuralink external_handoff Processed 📜 Receipt
2024-04-29 UNVERIFIED Stablecoin Giant Tether Invests $200M In Brain-Computer Interface Startup Blackr… external_handoff Processed 📜 Receipt
— UNVERIFIED Our Tech | Blackrock Neurotech external_handoff Processed 📜 Receipt
2021-05-19 UNVERIFIED Blackrock Neurotech Closes $10M Financing Round external_handoff Processed 📜 Receipt
2026 UNVERIFIED Research: Blackrock Neurotech — Lobbying disclosures (no results) government_disclosure Processed 📜 Receipt
2026 UNVERIFIED Research: Blackrock Neurotech — Corporate registrations (no results) government_disclosure Processed 📜 Receipt
2026 UNVERIFIED Research: Blackrock Neurotech — USASpending contracts (no results) contract Processed 📜 Receipt
2023-02-23 ↗ SEC EDGAR: filing — Blackrock Neurotech (2023-02-23) web_search Processed 📜 Receipt